BSE Live
Dec 24, 16:01Prev. Close
1979.95
Open Price
1972.55
Bid Price (Qty.)
1955.00 (10)
Offer Price (Qty.)
1999.00 (5)
NSE Live
Dec 24, 15:41Prev. Close
1981.00
Open Price
1978.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Caplin Point Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 | |
| Total Share Capital | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 | |
| Reserves and Surplus | 2,760.71 | 2,225.94 | 1,775.35 | 1,385.24 | 1,155.90 | |
| Total Reserves and Surplus | 2,760.71 | 2,225.94 | 1,775.35 | 1,385.24 | 1,155.90 | |
| Total Shareholders Funds | 2,775.91 | 2,241.13 | 1,805.90 | 1,409.35 | 1,185.82 | |
| Minority Interest | 35.90 | 31.12 | 26.79 | 25.95 | 17.54 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | |
| Other Long Term Liabilities | 13.73 | 11.40 | 8.35 | 12.70 | 16.24 | |
| Long Term Provisions | 1.74 | 8.61 | 7.78 | 6.06 | 0.00 | |
| Total Non-Current Liabilities | 15.47 | 20.01 | 16.13 | 18.76 | 17.39 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.55 | 0.28 | 3.41 | 0.50 | 17.07 | |
| Trade Payables | 217.58 | 209.41 | 164.37 | 163.18 | 88.50 | |
| Other Current Liabilities | 64.28 | 110.50 | 99.94 | 41.44 | 37.20 | |
| Short Term Provisions | 23.58 | 11.09 | 0.28 | 2.56 | 0.09 | |
| Total Current Liabilities | 305.99 | 331.28 | 268.00 | 207.68 | 142.85 | |
| Total Capital And Liabilities | 3,207.85 | 2,698.12 | 2,191.40 | 1,736.32 | 1,363.61 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 534.51 | 440.14 | 268.87 | 278.04 | 298.10 | |
| Intangible Assets | 11.27 | 12.52 | 10.94 | 8.53 | 7.29 | |
| Capital Work-In-Progress | 139.22 | 116.62 | 220.48 | 15.41 | 13.82 | |
| Fixed Assets | 689.28 | 569.28 | 500.52 | 304.30 | 319.22 | |
| Non-Current Investments | 279.13 | 137.63 | 70.52 | 37.01 | 0.66 | |
| Deferred Tax Assets [Net] | 2.23 | 12.55 | 13.83 | 6.21 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 7.92 | |
| Other Non-Current Assets | 103.26 | 85.74 | 52.07 | 90.98 | 0.00 | |
| Total Non-Current Assets | 1,073.90 | 805.20 | 636.94 | 438.50 | 327.80 | |
| CURRENT ASSETS | ||||||
| Current Investments | 311.33 | 237.98 | 159.17 | 51.97 | 10.54 | |
| Inventories | 336.10 | 363.04 | 288.22 | 227.31 | 179.00 | |
| Trade Receivables | 632.49 | 542.72 | 394.06 | 320.06 | 279.36 | |
| Cash And Cash Equivalents | 591.41 | 552.74 | 493.48 | 462.99 | 459.58 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 98.90 | |
| OtherCurrentAssets | 262.62 | 196.44 | 219.53 | 235.49 | 8.44 | |
| Total Current Assets | 2,133.95 | 1,892.92 | 1,554.46 | 1,297.82 | 1,035.81 | |
| Total Assets | 3,207.85 | 2,698.12 | 2,191.40 | 1,736.32 | 1,363.61 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 218.84 | 115.03 | 257.94 | 124.66 | 62.15 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 1.09 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 276.42 | 136.54 | 68.30 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 96.45 | 35.99 | 21.00 | 0.00 | 11.20 | |
| Current Investments Unquoted Book Value | 214.88 | 201.99 | 0.00 | 0.00 | 0.70 |
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
28.08.2025
21.08.2025
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y